5-Azacytidine suppresses the incidence of abdominal aortic aneurysm through the epigenetic regulation of macrophage polarization
- 1Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
- 2Department of Vascular Surgery, NHO Kyushu Medical Center, Fukuoka, Japan
Abstract
Objective: Abdominal aortic aneurysm (AAA) is a life-threatening disease characterized by chronic vascular inflammation and extracellular matrix degradation. Macrophage polarization and epigenetic regulation via DNA methylation contribute to AAA pathogenesis. This study aimed to investigate the effects of DNA methyltransferase 1 (DNMT1) inhibitor 5-azacytidine (5-aza) on AAA development and its underlying mechanisms.
Methods: Apolipoprotein E knockout mice were infused with angiotensin II (Ang II) to induce AAA formation and treated with 5-aza or left untreated. Histological and immunohistochemical analyses were performed to evaluate DNA methylation status and macrophage phenotype. In vitro, RAW 264.7 macrophages were stimulated with Ang II with or without 5-aza, followed by immunostaining, reverse transcription quantitative polymerase chain reaction, and Western blotting. DNMT1 was silenced using small-interfering RNA. Promoter methylation status was evaluated by methylation-specific polymerase chain reaction. Publicly available bulk microarray datasets were analyzed to support the experimental findings.
Results: 5-Aza considerably reduced AAA incidence and elastin degradation in Ang II–infused apolipoprotein E knockout mice. It suppressed DNMT1 expression and global DNA methylation in the abdominal aorta and reduced M1/M2 macrophage ratio, as evidenced by decreased proinflammatory M1 macrophages. In vitro, 5-aza inhibited macrophage proliferation, migration, and matrix metalloproteinase expression. Bulk microarray analysis data supported these findings, demonstrating DNMT1 upregulation and peroxisome proliferator-activated receptor gamma (PPARγ) downregulation in Ang II treated aortas. 5-Aza reduced methylation of the Pparg promoter in vivo and in vitro, which was associated with increased PPARγ expression and a reduced M1/M2 macrophage ratio.
Conclusions: 5-Aza suppresses AAA formation by epigenetically regulating macrophage polarization through modulation of Pparg promoter methylation. Targeting DNA methylation represents a potential therapeutic strategy for AAA.
Clinical relevance: There is currently no established pharmacological therapy for abdominal aortic aneurysm (AAA). We demonstrate that DNA methyltransferase 1 inhibition by 5-azacytidine suppresses AAA formation by reducing DNA methylation and the M1/M2 macrophage ratio via upregulation of peroxisome proliferator-activated receptor γ expression. These findings identify epigenetic regulation as a key mechanism in AAA pathogenesis. Given that 5-azacytidine is already clinically available, targeting DNA methylation may represent a potential translational strategy to inhibit AAA formation, although optimization of dosing and safety will be required.
Related
- Tangeretin ameliorates osteoarthritis and suppresses synovial macrophage M1 polarization in association with suppression of NF-κB signaling
- Overexpression of TUBA1A suppresses bladder cancer progression with potential modulation of autophagic activity and macrophage polarization
- Mapping intestinal microenvironment heterogeneity in Hirschsprung's disease by spatial transcriptomics: Role of THBS1 in macrophage polarization and neural stem cell regulation.
- Magnesium cantharidate suppresses hepatocellular carcinoma progression and modulates tumor-associated macrophage polarization: potential involvement of ERK1/2 signaling and de novo serine synthesis
- Dynamic Changes in Macrophage Infiltration and Polarization During Oral Carcinogenesis and Tumor Progression
BibTeX
@article{kinoshita20265azacytidine,
title = {{5-Azacytidine suppresses the incidence of abdominal aortic aneurysm through the epigenetic regulation of macrophage polarization}},
author = {Go Kinoshita and Kentaro Inoue and Kohei Ueno and Yusuke Fujioka and Shinichiro Yoshino and Koichi Morisaki and Tadashi Furuyama and Tomoharu Yoshizumi},
journal = {JVS-Vascular Science},
year = {2026},
month = sep,
doi = {10.1016/j.jvssci.2026.100447},
url = {https://doi.org/10.1016/j.jvssci.2026.100447},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - 5-Azacytidine suppresses the incidence of abdominal aortic aneurysm through the epigenetic regulation of macrophage polarization
AU - Go Kinoshita
AU - Kentaro Inoue
AU - Kohei Ueno
AU - Yusuke Fujioka
AU - Shinichiro Yoshino
AU - Koichi Morisaki
AU - Tadashi Furuyama
AU - Tomoharu Yoshizumi
PY - 2026
DA - 2026/09/16
JO - JVS-Vascular Science
DO - 10.1016/j.jvssci.2026.100447
UR - https://doi.org/10.1016/j.jvssci.2026.100447
AB - Objective: Abdominal aortic aneurysm (AAA) is a life-threatening disease characterized by chronic vascular inflammation and extracellular matrix degradation. Macrophage polarization and epigenetic regulation via DNA methylation contribute to AAA pathogenesis. This study aimed to investigate the effects of DNA methyltransferase 1 (DNMT1) inhibitor 5-azacytidine (5-aza) on AAA development and its underlying mechanisms. Methods: Apolipoprotein E knockout mice were infused with angiotensin II (Ang II) to induce AAA formation and treated with 5-aza or left untreated. Histological and immunohistochemical analyses were performed to evaluate DNA methylation status and macrophage phenotype. In vitro, RAW 264.7 macrophages were stimulated with Ang II with or without 5-aza, followed by immunostaining, reverse transcription quantitative polymerase chain reaction, and Western blotting. DNMT1 was silenced using small-interfering RNA. Promoter methylation status was evaluated by methylation-specific polymerase chain reaction. Publicly available bulk microarray datasets were analyzed to support the experimental findings. Results: 5-Aza considerably reduced AAA incidence and elastin degradation in Ang II–infused apolipoprotein E knockout mice. It suppressed DNMT1 expression and global DNA methylation in the abdominal aorta and reduced M1/M2 macrophage ratio, as evidenced by decreased proinflammatory M1 macrophages. In vitro, 5-aza inhibited macrophage proliferation, migration, and matrix metalloproteinase expression. Bulk microarray analysis data supported these findings, demonstrating DNMT1 upregulation and peroxisome proliferator-activated receptor gamma (PPARγ) downregulation in Ang II treated aortas. 5-Aza reduced methylation of the Pparg promoter in vivo and in vitro, which was associated with increased PPARγ expression and a reduced M1/M2 macrophage ratio. Conclusions: 5-Aza suppresses AAA formation by epigenetically regulating macrophage polarization through modulation of Pparg promoter methylation. Targeting DNA methylation represents a potential therapeutic strategy for AAA. Clinical relevance: There is currently no established pharmacological therapy for abdominal aortic aneurysm (AAA). We demonstrate that DNA methyltransferase 1 inhibition by 5-azacytidine suppresses AAA formation by reducing DNA methylation and the M1/M2 macrophage ratio via upregulation of peroxisome proliferator-activated receptor γ expression. These findings identify epigenetic regulation as a key mechanism in AAA pathogenesis. Given that 5-azacytidine is already clinically available, targeting DNA methylation may represent a potential translational strategy to inhibit AAA formation, although optimization of dosing and safety will be required.
SN - 2666-3503
ER -